A malignant gastrointestinal stromal tumour in a patient with multiple endocrine neoplasia type 1

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 2, 2001, Pages 207-211

  Papillon, Emmanuel ^a   Rolachon, Alain ^a   Calender, Alain ^a   Chabre, Olivier ^a   Barnoud, Raphaëlle ^a   Fournet, Jacques ^a  

^a Département d Hépato Gastro Enterologie   (United States)

Author keywords

Keywords; Loss of heterozygosity; Malignant gastrointestinal stromal tumour; Multiple endocrine neoplasia type 1

Indexed keywords

DNA;

ADULT; ARTICLE; CARCINOGENESIS; CASE REPORT; DISEASE ASSOCIATION; DNA POLYMORPHISM; FRAMESHIFT MUTATION; GASTROINTESTINAL TUMOR; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE ENDOCRINE NEOPLASIA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; CHROMOSOMES, HUMAN, PAIR 11; DNA, NEOPLASM; GASTRINOMA; GASTROINTESTINAL NEOPLASMS; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NEOPLASMS, MULTIPLE PRIMARY; POLYMORPHISM, GENETIC;

EID: 0035131330     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-200102000-00021     Document Type: Article

References (35)

1. Antonioli DA. Gastrointestinal autonomic nerve tumours.: Expanding the spectrum of gastrointestinal stromal tumours. Arch Pathol Lab Med 1989; 113: 831 -833.
2. Shiu MH, Farr GH, Papachristou DN, Hadju SI. Myosarcomas of the stomach: natural history, prognostic factors and management. Cancer 1982; 49: 177 -187.
3. Appelmann HD, Helwig EB. Gastric epithelioid leiomyoma and leiomyosarcoma (leiomyoblastoma). Cancer 1976; 38: 708 -728.
4. Lavin P, Hajdu SI, Foote FW Jr. Gastric and extragastric leiomyoblastomas: a clinico-pathological study of 44 cases. Cancer 1972; 29: 305 -311.
5. Tallqvist G, Salmela H, Lindstrom BL. Leiomyoblastoma of the stomach: a clinico-pathological study of 10 cases. Acta Pathol Microbiol Scand 1967; 71: 194 -202.
6. Lee JSY, Nascimento AG, Farnell MB, Carney JA, Harmsen WS, Ilstrup DM. Epithelioid gastric stromal tumours (leiomyoblastomas): a study of 55 cases. Surgery 1995; 118: 653 -661.
7. Ballarini C, Intra M, Cerreti AP, Prestipino F, Bianchi FM, Sparacio F. et al. Gastrointestinal stromal tumours: a ‘benign’ tumour with hepatic metastasis after 11 years. tumouri 1998; 84: 78 -81.
8. Agarwal SK, Kester MB, Debelenko LV, Heppner C, Emmert-Buck MR, Skarulis MC. et al. Germline mutations of the MEN-1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet 1997; 6: 1169 -1175.
9. Larsson C, Skogseid B, Öberg K, Nakamura Y, Nordenskjöld M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and lost in insulinoma. Nature 1988; 332: 85 -87.
10. Bale SJ, Bale AE, Stewart K, Dachowski L, McBride OW, Glaser T. et al. Linkage analysis of multiple endocrine neoplasia type 1 with INT2 and other markers on chromosome 11. Genomics 1989; 4: 320 -322.
11. Metz DC, Jensen RT, Bale AE, Skarulis MC, Eastman RC, Nieman L. et al. Multiple endocrine neoplasia type 1: clinical features and management. In:The Parathyroids: Basic and Clinical Concepts. Bilezikian JP, Marcus R, Levine MA (editors). New York: Raven Press; 1994: 591 -646.
12. Friedman E, Sakaguchi K, Bale AE, Falchetti A, Streeten E, Zimering MB. et al. Clonality of parathyroid tumours in familial multiple endocrine neoplasia type 1. N Engl J Med 1989; 321: 213 -218.
13. Thakker RV, Bouloux P, Wooding C, Chotai K, Broad PM, Spurr NK. et al. Association of parathyroid tumours in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med 1989; 321: 218 -224.
14. Radford DM, Ashley SW, Wells SA, Gerhard DS. Loss of heterozygosity of markers on chromosome 11 in tumours from patients with multiple endocrine neoplasia type 1. Cancer Res 1990; 50: 6529 -6533.
15. Dong Q, Debelenko LV, Chandrasekharappa SC, Emmert-Buck MR, Zhuang Z, Guru SC. et al. Loss of heterozygosity at 11q13: analysis of pituitary tumours, lung carcinoids, lipomas, and other uncommon tumours in subjects with familial multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 1997; 82: 1416 -1420.
16. Cadiot G, Laurent-Puig P, Thuille B, Lehy T, Mignon M, Olschwang S. Is the multiple endocrine neoplasia type 1 gene a suppressor for fundic argyrophil tumours in the Zollinger-Ellison Syndrome? Gastroenterology 1993; 105: 579 -582.
17. Debelenko LV, Emmert-Buck MR, Zhuang Z, Epshteyn E, Moskaluk CA, Jensen RT. et al. The multiple endocrine neoplasia type 1 gene locus is involved in the pathogenesis of type II gastric carcinoids. Gastroenterology 1997; 113: 773 -781.
18. Burton JL, Hartog M. Multiple endocrine adenomatosis (type 1) with cutaneous leiomyomata and cysts of Moll [Letter]. Br J Dermatol 1977; 15: 74. 74.
19. Carnevale V, Romagnoli E, Remotti D, D'Erasmo E, Spagna G, Pisani D. et al. Pulmonary lymphangioleiomyoma in a patient with multiple endocrine neoplasia type 1. J Endocrinol Invest 1997; 20: 282 -285.
20. Larraza-Hernandez O, Albores-Saavedra J, Benavides G, Krause LG, Perez-Merizaldi JC, Ginzo A. Multiple endocrine neoplasia. Am J Clin Pathol 1982; 78: 527 -532.
21. Kubben FJGM, Kroon FP, Hogendoorn PCW, Chandie Shaw P, Weenendaal P, De Ross A. Absence of Epstein-Barr virus (EBV) in a gastrointestinal stromal cell tumour in an adult human immunodeficiency virus-seropositive patient with past EBV infection. Eur J Gastroenterol Hepatol 1997; 9: 721 -724.
22. Danzig JB, Brandt LJ, Reinus JF. Gastrointestinal malignancy in patients with AIDS. Am J Gastroenterol 1991; 86: 715 -718.
23. McClain KL, Leach CT, Jenson HB, Leibowitz D. Association of EBV with leiomyosarcomas in young people with AIDS. N Engl J Med 1995; 332: 12 -18.
24. Fuller CE, Williams GT. Gastrointestinal manifestations of type I neurofibromatosis (von Recklinghausen's disease). Histopathology 1991; 19: 1 -11.
25. Carney JA. The triad of gastric epithelioid leiomyosarcoma, pulmonary chondroma and functioning extra-adrenal paraganglioma.: A five-year review. Medicine 1983; 62: 159 -169.
26. Sircar K, Hewlett BR, Huizinga JD, Chorneyko K, Berezin I, Riddell RH. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumours. Am J Surg Pathol 1999; 23: 377 -389.
27. Rosai J. Gastrointestinal tract. In:Ackermans's Surgical Pathology, 8th edn. Rosai J (editor). St Louis: Mosby; 1996: 645 -647.
28. Erlandson RA, Klimstra DS, Woodruff JM. Subclassification of gastrointestinal stromal tumours based on evaluation by electron microscopy and immunohistochemistry. Ultrastruct Pathol 1996; 20: 373 -393.
29. Miettinen M, Virolainen M, Maarit-Sarlomo R. Gastrointestinal stromal tumours: value of CD34 antigen in their identification and separation from true leiomyomas and Schwannomas. Am J Surg Pathol 1995; 19: 207 -216.
30. Amin MB, Ma CK, Linden MD, Kubus JJ, Zarbo RJ. Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumours.: Correlation with mitotic count and clinical outcome. Am J Clin Pathol 1993; 100: 428 -432.
31. Franquemont DW. Differentiation and risk assessment of gastrointestinal stromal tumours. Am J Clin Pathol 1995; 103: 41 -47.
32. Lubensky IA, Debelenko LV, Zhuang Z, Emmert-Buck MR, Dong Q, Chandrasekharappa S. et al. Allelic deletions on chromosome 11q13 in multiple tumours from individual MEN-1 patients. Cancer Res 1996; 56: 5272 -5278.
33. Beckers A, Abs R, Reyniers E, De Boulle K, Steavenaert A, Heller FR. et al. Variable regions of chromosome 11 loss in different pathological tissues of a patient with multiple endocrine neoplasia type 1 syndrome. J Clin Endocrinol Metab 1994; 79: 1498 -1502.
34. Giraud S, Zhang CX, Serova-Sinilnikova O, Wautot V, Salandre J, Buisson N. et al. Germline mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. Hum Mol Genet 1998; 63: 455 -467.
35. Colman SD, Williams CA, Wallace MR. Benign neurofibromas in type I neurofibromatosis (NF1) show somatic deletions in the NF1 gene. Nat Genet 1995; 11: 90 -92.